These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8090278)

  • 1. In man the mu-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide.
    Auernhammer CJ; Riepl RL; Schopohl J; Lehnert P; Müller OA; Stalla GK
    Neuroendocrinology; 1994 Jul; 60(1):16-22. PubMed ID: 8090278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro.
    Auernhammer CJ; Stalla GK; Lange M; Pfeiffer A; Müller OA
    J Clin Endocrinol Metab; 1992 Aug; 75(2):552-7. PubMed ID: 1322429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loperamide inhibits corticotrophic cell function by a naloxone-insensitive mechanism in the rat in vitro.
    Auernhammer CJ; Renner U; Müller OA; Stalla J; Stalla GK
    Neuroendocrinology; 1993 Jun; 57(6):1019-27. PubMed ID: 8232760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the opiate agonist loperamide on pituitary-adrenal function in patients with suspected hypercortisolism.
    Ambrosi B; Bochicchio D; Ferrario R; Colombo P; Faglia G
    J Endocrinol Invest; 1989 Jan; 12(1):31-5. PubMed ID: 2545766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
    Otto B; Mawe GM; Riepl RL
    Neurogastroenterol Motil; 2005 Oct; 17(5):761-6. PubMed ID: 16185316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the suppressive effects of dexamethasone and loperamide on cortisol and ACTH secretion in some pathological conditions.
    Bernini GP; Argenio GF; Cerri F; Franchi F
    J Endocrinol Invest; 1994 Nov; 17(10):799-804. PubMed ID: 7699214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man.
    Hensen J; Hader O; Bähr V; Oelkers W
    J Clin Endocrinol Metab; 1988 Apr; 66(4):668-71. PubMed ID: 2831245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loperamide, an opiate analogue, inhibits plasma ACTH levels in patients with Addison's disease.
    Ambrosi B; Bochicchio D; Faglia G
    Clin Endocrinol (Oxf); 1986 May; 24(5):483-9. PubMed ID: 3024866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of vagus-mediated pancreatic polypeptide release by the mu-opiate receptor agonist loperamide in man.
    Riepl RL; Reichardt B; Auernhammer CJ; Beier G; Schopohl J; Stalla GK; Lehnert P
    Br J Clin Pharmacol; 1996 Sep; 42(3):371-7. PubMed ID: 8877029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loperamide, an opiate analog, differently modifies the adrenocorticotropin responses to corticotropin-releasing hormone and lysine vasopressin in patients with Addison's disease.
    Bochicchio D; Ambrosi B; Faglia G
    Neuroendocrinology; 1988 Dec; 48(6):611-4. PubMed ID: 2855105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
    Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man.
    Watabe T; Tanaka K; Kumagae M; Itoh S; Kogure M; Hasegawa M; Horiuchi T; Morio K; Takeda F; Ubukata E
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1132-7. PubMed ID: 2836468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
    Buyalos RP; Jackson RV; Grice GI; Hockings GI; Torpy DJ; Fox LM; Boots LR; Azziz R
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3219-24. PubMed ID: 9745431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
    Inder WJ; Hellemans J; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    J Clin Endocrinol Metab; 1995 Jan; 80(1):244-8. PubMed ID: 7829620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
    Arvat E; Maccagno B; Giordano R; Pellegrino M; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1).
    Hernandez-Avila CA; Wand G; Luo X; Gelernter J; Kranzler HR
    Am J Med Genet B Neuropsychiatr Genet; 2003 Apr; 118B(1):60-5. PubMed ID: 12627468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercise in man.
    Coiro V; Volpi R; Casti A; Maffei ML; Stella A; Volta E; Chiodera P
    Br J Clin Pharmacol; 2011 Jun; 71(6):951-5. PubMed ID: 21564163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin reduces exercise-induced ACTH and cortisol rise in man.
    Coiro V; Passeri M; Davoli C; Bacchi-Modena A; Bianconi L; Volpi R; Chiodera P
    Acta Endocrinol (Copenh); 1988 Nov; 119(3):405-12. PubMed ID: 2847472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.